412 related articles for article (PubMed ID: 16400828)
1. Animal models for multiple sclerosis.
Owens T
Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
[No Abstract] [Full Text] [Related]
2. New concepts in the immunopathogenesis of multiple sclerosis.
Hemmer B; Archelos JJ; Hartung HP
Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
[No Abstract] [Full Text] [Related]
3. [Experimental autoimmune encephalomyelitis].
Cornet A; Vizler C; Liblau R
Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
[TBL] [Abstract][Full Text] [Related]
4. New insights into adaptive immunity in chronic neuroinflammation.
Siffrin V; Brandt AU; Herz J; Zipp F
Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the evidence for multiple sclerosis as an autoimmune disease.
Altmann D
Arch Neurol; 2005 Apr; 62(4):688; author reply 688-9. PubMed ID: 15824275
[No Abstract] [Full Text] [Related]
6. [Experimental allergic encephalomyelitis].
Juhler M
Ugeskr Laeger; 1985 Jan; 147(4):253-5. PubMed ID: 3976025
[No Abstract] [Full Text] [Related]
7. Acute disseminated encephalomyelitis: distinction from multiple sclerosis and treatment issues.
Wingerchuk DM
Adv Neurol; 2006; 98():303-18. PubMed ID: 16400841
[No Abstract] [Full Text] [Related]
8. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis.
Takeuchi H; Wang J; Kawanokuchi J; Mitsuma N; Mizuno T; Suzumura A
Neurobiol Dis; 2006 Apr; 22(1):33-9. PubMed ID: 16386911
[TBL] [Abstract][Full Text] [Related]
10. Encephalitogenic lymphoblast recruitment to resting CNS microvasculature: a natural immunosurveillance mechanism?
Alon R
J Clin Invest; 2001 Aug; 108(4):517-9. PubMed ID: 11518723
[No Abstract] [Full Text] [Related]
11. Experimental allergic encephalomyelitis as a guide to the understanding and treatment of multiple sclerosis.
Whitaker JN; Mitchell GW
Ann Neurol; 1993 Nov; 34(5):636-7. PubMed ID: 8239557
[No Abstract] [Full Text] [Related]
12. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
[TBL] [Abstract][Full Text] [Related]
13. Neurons tame T cells.
Fujinami RS
Nat Med; 2006 May; 12(5):503-4. PubMed ID: 16675991
[No Abstract] [Full Text] [Related]
14. T cell autoimmunity in the central nervous system--a new twist at an old rope.
Raine CS; Cross AH
Lab Invest; 1990 Feb; 62(2):133-4. PubMed ID: 2304329
[No Abstract] [Full Text] [Related]
15. Multiple sclerosis: human model for EAE?
Hohlfeld R
Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
[TBL] [Abstract][Full Text] [Related]
16. Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?
Alvord EC; Shaw CM; Hruby S; Kies MW
Ann Neurol; 1979 Dec; 6(6):461-8. PubMed ID: 93873
[TBL] [Abstract][Full Text] [Related]
17. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model.
McFarland HF
J Clin Invest; 1994 Sep; 94(3):921-2. PubMed ID: 8083376
[No Abstract] [Full Text] [Related]
18. B cells in spontaneous autoimmune diseases of the central nervous system.
Berer K; Wekerle H; Krishnamoorthy G
Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
[TBL] [Abstract][Full Text] [Related]
19. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of multiple sclerosis: an update on immunology.
Hemmer B; Cepok S; Nessler S; Sommer N
Curr Opin Neurol; 2002 Jun; 15(3):227-31. PubMed ID: 12045717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
